Status: Not yet recruiting
Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes
This is a prospective, multicenter, randomized, double-blind, sham-controlled, adaptive study evaluating the pulsENDO system in individuals with type 2 diabetes (T2D) inadequately controlled on non-insulin glucose-lowering medications (GLMs). The primary objective of this study is to demonstrate that pulsENDO therapy is superior to sham control for improving glycemic control in adults with type 2 diabetes.
Participants needed: 320
Trial details
Age: 22-75Biological sex: AllType: InterventionalSponsor: Endogenex, Inc.Updated: Aug 18, 2026
Eligibility criteria
22- 75 years of age, inclusive. [+11]
Diagnosed with type 1 diabetes. [+51]